What Is The Clearikon Touchless Transparent Bandage?
Our Touchless Bandage will help diabetic patients suffering from chronic wounds that won't heal.
We will change the way the world treats wounds.
The Problem: Healthcare Acquired Infections
According to the Center for Disease Control (CDC), surgical site infections, the most expensive type of Healthcare-Associated Infections (HAIs), annually costs about $3.3 billion, and extend hospital stays about an average of 9.7 days. HAIs increase hospitalization costs by an average of $20,000 per admission.
The US Department of Labor, forecasts a significant shortage of nurses in the US workforce. By 2025, there will be an estimated 250,000 fewer nurses in the US healthcare system. Nursing shortages will affect the quantity of patients that can receive treatment and the quality of patient wound care.
MRSA is a Common HAI
Methicillin-resistant Staphylococcus aureus (MRSA) is a type of staph bacteria that is resistant to certain antibiotics called beta-lactams. These antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin, and amoxicillin. Most MRSA infections are skin infections and more severe or potentially life-threatening MRSA infections occur most frequently among patients in healthcare settings. For more information, visit CDC’s MRSA web site.
Current Bandage Changing Methods Can Reopen Wound and Increase HAI Risk
Manually removing and changing a bandage made with gauze, foam or other band-aid type materials is labor intensive and painful. Patient wounds are reopened every time a bandage is changed. Nurses will remove a bandage to inspect and treat the wound with medication. Unfortunately each time a bandage is changed, the wound is exposed and with an increased risk of contact with bacteria and Healthcare-Associated Infections (HAIs).
The Solution: The Clearikon Touchless Transparent Bandage
The Clearikon Touchless Transparent Bandage is a patented medical device with visual wound monitoring and drug delivery without removing the bandage.
Our bandage is:
Easy to apply and easy to remove
A new bandage can be changed in less than five minutes
Bandage does not contact the wound so the patient's wound is not reopened when the bandage is changed
The decision to change or not to change can be made quickly and only when necessary
A nurse can always see the wound
Wounds can be monitored via smartphone
Designed to work with third-party wound care products so adoption will be easy
Can be used for drug delivery and administrating new topical therapies via integrated injection ports
Competitive Advantages
Our first patent was issued in February 2021. We filed two additional patents in 2022 and 2023. Our Intellectual Property is based on years of scientific research. Our Clearikon bandage is designed and manufactured using 3D printing technology. Components are based on proprietary processes and materials. There is no comparable product on the market.
Next Steps
Our Clearikon Touchless Transparent Bandage is in its final stage of development. We are working with physicians and nurses on User Preference Trials. We will use our animal and human clinical trials to file a 510(k) application with the FDA. Our Touchless Bandage products will be sold through independent sales reps and distributors to hospitals, clinics, nursing homes, home health care organizations, universities, and pharmaceutical companies.
Learn more about our company and revolutionary products. Stay in Touch through our Contact Us page.